Global Urological Cancer Therapeutics Drugs Market Research Report 2021

Global Urological Cancer Therapeutics Drugs Market Research Report 2021

Table of Contents
1 Urological Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs
1.2 Urological Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Urological Cancer Therapeutics Drugs Segment by Application
1.3.1 Urological Cancer Therapeutics Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Global Urological Cancer Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Urological Cancer Therapeutics Drugs Revenue 2016-2027
1.4.2 Global Urological Cancer Therapeutics Drugs Sales 2016-2027
1.4.3 Urological Cancer Therapeutics Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Urological Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Urological Cancer Therapeutics Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Urological Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Urological Cancer Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Urological Cancer Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urological Cancer Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Urological Cancer Therapeutics Drugs Sales by Country
3.3.2 North America Urological Cancer Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Urological Cancer Therapeutics Drugs Sales by Country
3.4.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Urological Cancer Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Urological Cancer Therapeutics Drugs Sales by Country
3.6.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Urological Cancer Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
4.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Urological Cancer Therapeutics Drugs Price by Type (2016-2021)
5 Global Urological Cancer Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
5.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Urological Cancer Therapeutics Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Astellas
6.5.1 Astellas Corporation Information
6.5.2 Astellas Description and Business Overview
6.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Astellas Product Portfolio
6.5.5 Astellas Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bristol-Myers Squibb Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abbott Laboratories Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Celgene Corporation
6.8.1 Celgene Corporation Corporation Information
6.8.2 Celgene Corporation Description and Business Overview
6.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Celgene Corporation Product Portfolio
6.8.5 Celgene Corporation Recent Developments/Updates
6.9 Dendreon Corporation
6.9.1 Dendreon Corporation Corporation Information
6.9.2 Dendreon Corporation Description and Business Overview
6.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Dendreon Corporation Product Portfolio
6.9.5 Dendreon Corporation Recent Developments/Updates
6.10 Ferring Pharmaceuticals
6.10.1 Ferring Pharmaceuticals Corporation Information
6.10.2 Ferring Pharmaceuticals Description and Business Overview
6.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ferring Pharmaceuticals Product Portfolio
6.10.5 Ferring Pharmaceuticals Recent Developments/Updates
6.11 GlaxoSmithKline plc
6.11.1 GlaxoSmithKline plc Corporation Information
6.11.2 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Description and Business Overview
6.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GlaxoSmithKline plc Product Portfolio
6.11.5 GlaxoSmithKline plc Recent Developments/Updates
6.12 Indevus Pharmaceuticals Inc
6.12.1 Indevus Pharmaceuticals Inc Corporation Information
6.12.2 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Description and Business Overview
6.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Indevus Pharmaceuticals Inc Product Portfolio
6.12.5 Indevus Pharmaceuticals Inc Recent Developments/Updates
6.13 Ipsen
6.13.1 Ipsen Corporation Information
6.13.2 Ipsen Urological Cancer Therapeutics Drugs Description and Business Overview
6.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ipsen Product Portfolio
6.13.5 Ipsen Recent Developments/Updates
6.14 Roche Healthcare
6.14.1 Roche Healthcare Corporation Information
6.14.2 Roche Healthcare Urological Cancer Therapeutics Drugs Description and Business Overview
6.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Roche Healthcare Product Portfolio
6.14.5 Roche Healthcare Recent Developments/Updates
6.15 Sanofi S.A.
6.15.1 Sanofi S.A. Corporation Information
6.15.2 Sanofi S.A. Urological Cancer Therapeutics Drugs Description and Business Overview
6.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sanofi S.A. Product Portfolio
6.15.5 Sanofi S.A. Recent Developments/Updates
7 Urological Cancer Therapeutics Drugs Manufacturing Cost Analysis
7.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
7.4 Urological Cancer Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Urological Cancer Therapeutics Drugs Distributors List
8.3 Urological Cancer Therapeutics Drugs Customers
9 Urological Cancer Therapeutics Drugs Market Dynamics
9.1 Urological Cancer Therapeutics Drugs Industry Trends
9.2 Urological Cancer Therapeutics Drugs Growth Drivers
9.3 Urological Cancer Therapeutics Drugs Market Challenges
9.4 Urological Cancer Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Urological Cancer Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Urological Cancer Therapeutics Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Urological Cancer Therapeutics Drugs by Type (2022-2027)
10.2 Urological Cancer Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Urological Cancer Therapeutics Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Urological Cancer Therapeutics Drugs by Application (2022-2027)
10.3 Urological Cancer Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Urological Cancer Therapeutics Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Urological Cancer Therapeutics Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Urological Cancer Therapeutics Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Urological Cancer Therapeutics Drugs Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Urological Cancer Therapeutics Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Urological Cancer Therapeutics Drugs Covered in This Study
Table 5. Global Urological Cancer Therapeutics Drugs Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Urological Cancer Therapeutics Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Urological Cancer Therapeutics Drugs Product Type
Table 12. Global Urological Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Urological Cancer Therapeutics Drugs Sales by Region (2016-2021) & (K MT)
Table 16. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 19. North America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 23. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2016-2021)
Table 39. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Urological Cancer Therapeutics Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 42. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Type (2016-2021)
Table 43. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2016-2021)
Table 44. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Urological Cancer Therapeutics Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2016-2021)
Table 47. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novartis Urological Cancer Therapeutics Drugs Product
Table 52. Novartis Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Pfizer Urological Cancer Therapeutics Drugs Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Urological Cancer Therapeutics Drugs Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. AstraZeneca Corporation Information
Table 64. AstraZeneca Description and Business Overview
Table 65. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. AstraZeneca Urological Cancer Therapeutics Drugs Product
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Astellas Corporation Information
Table 69. Astellas Description and Business Overview
Table 70. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Astellas Urological Cancer Therapeutics Drugs Product
Table 72. Astellas Recent Developments/Updates
Table 73. Bristol-Myers Squibb Corporation Information
Table 74. Bristol-Myers Squibb Description and Business Overview
Table 75. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Abbott Laboratories Corporation Information
Table 79. Abbott Laboratories Description and Business Overview
Table 80. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Abbott Laboratories Urological Cancer Therapeutics Drugs Product
Table 82. Abbott Laboratories Recent Developments/Updates
Table 83. Celgene Corporation Corporation Information
Table 84. Celgene Corporation Description and Business Overview
Table 85. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Celgene Corporation Urological Cancer Therapeutics Drugs Product
Table 87. Celgene Corporation Recent Developments/Updates
Table 88. Dendreon Corporation Corporation Information
Table 89. Dendreon Corporation Description and Business Overview
Table 90. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Dendreon Corporation Urological Cancer Therapeutics Drugs Product
Table 92. Dendreon Corporation Recent Developments/Updates
Table 93. Ferring Pharmaceuticals Corporation Information
Table 94. Ferring Pharmaceuticals Description and Business Overview
Table 95. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product
Table 97. Ferring Pharmaceuticals Recent Developments/Updates
Table 98. GlaxoSmithKline plc Corporation Information
Table 99. GlaxoSmithKline plc Description and Business Overview
Table 100. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product
Table 102. GlaxoSmithKline plc Recent Developments/Updates
Table 103. Indevus Pharmaceuticals Inc Corporation Information
Table 104. Indevus Pharmaceuticals Inc Description and Business Overview
Table 105. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product
Table 107. Indevus Pharmaceuticals Inc Recent Developments/Updates
Table 108. Ipsen Corporation Information
Table 109. Ipsen Description and Business Overview
Table 110. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Ipsen Urological Cancer Therapeutics Drugs Product
Table 112. Ipsen Recent Developments/Updates
Table 113. Roche Healthcare Corporation Information
Table 114. Roche Healthcare Description and Business Overview
Table 115. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Roche Healthcare Urological Cancer Therapeutics Drugs Product
Table 117. Roche Healthcare Recent Developments/Updates
Table 118. Sanofi S.A. Corporation Information
Table 119. Sanofi S.A. Description and Business Overview
Table 120. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Sanofi S.A. Urological Cancer Therapeutics Drugs Product
Table 122. Sanofi S.A. Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Urological Cancer Therapeutics Drugs Distributors List
Table 126. Urological Cancer Therapeutics Drugs Customers List
Table 127. Urological Cancer Therapeutics Drugs Market Trends
Table 128. Urological Cancer Therapeutics Drugs Growth Drivers
Table 129. Urological Cancer Therapeutics Drugs Market Restraints
Table 130. Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 131. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 135. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Urological Cancer Therapeutics Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 139. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Urological Cancer Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urological Cancer Therapeutics Drugs
Figure 2. Global Urological Cancer Therapeutics Drugs Market Share by Type in 2020 & 2027
Figure 3. Xofigo (radium Ra 223 dichloride) Product Picture
Figure 4. Jevtana (cabazitaxel) Product Picture
Figure 5. Inlyta (axitinib) Product Picture
Figure 6. Votrient (pazopanib hydrochloride) Product Picture
Figure 7. Sutent (sunitinib malate) Product Picture
Figure 8. Zytiga (abiraterone acetate) Product Picture
Figure 9. Xtandi (enzalutamide) Product Picture
Figure 10. Opdivo (nivolumab) Product Picture
Figure 11. Provenge (sipuleucel-T) Product Picture
Figure 12. Global Urological Cancer Therapeutics Drugs Market Share by Application in 2020 & 2027
Figure 13. Hospital
Figure 14. Medical Research Laboratory
Figure 15. Others
Figure 16. Global Urological Cancer Therapeutics Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Urological Cancer Therapeutics Drugs Market Size 2016-2027 (US$ Million)
Figure 18. Global Urological Cancer Therapeutics Drugs Sales 2016-2027 (K MT)
Figure 19. Global Urological Cancer Therapeutics Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Urological Cancer Therapeutics Drugs Sales Share by Manufacturers in 2020
Figure 21. Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Urological Cancer Therapeutics Drugs Players: Market Share by Revenue in 2020
Figure 23. Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
Figure 25. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region in 2020
Figure 26. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Figure 27. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 28. U.S. Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Urological Cancer Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Urological Cancer Therapeutics Drugs by Type (2016-2021)
Figure 53. Sales Market Share of Urological Cancer Therapeutics Drugs by Application (2016-2021)
Figure 54. Sales Market Share of Urological Cancer Therapeutics Drugs by Application in 2020
Figure 55. Revenue Share of Urological Cancer Therapeutics Drugs by Application (2016-2021)
Figure 56. Revenue Share of Urological Cancer Therapeutics Drugs by Application in 2020
Figure 57. Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure 58. Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure 59. Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs